Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5697610 | Cancer Treatment Reviews | 2017 | 44 Pages |
Abstract
In HER2-positive breast cancer, high baseline TIL are associated with increased pCR probability irrespective of neoadjuvant anti-HER2 agent(s) and chemotherapy regimens used.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
C. Solinas, M. Ceppi, M. Lambertini, M. Scartozzi, L. Buisseret, S. Garaud, D. Fumagalli, E. de Azambuja, R. Salgado, C. Sotiriou, K. Willard-Gallo, M. Ignatiadis,